Software aids cancer diagnostics; biomarker test evaluates glioblastoma treatments;

> BioImagene has unveiled specialized algorithms for use with its Virtuoso software that can help pathologists assess diagnostic tests that indicate patient suitability for specific cancer therapies. Announcement

> DecisionDx-GBM is a biomarker test available from Castle Biosciences that helps predict patient outcomes to treatment options for glioblastoma multiforme, the brain cancer to which U.S. Senator Edward Kennedy succumbed. Release

> The J. David Gladstone Institutes and Alitora Systems have teamed to further develop Alitora's biotech and pharmaceutical organization collaboration software, tapping the Institute's store of bioinformatics know-how. Article

> Pacific Biosciences researcher Eric Schadt, in combining mathematics, biology and supercomputers, is finding that the mechanisms of human disease may be far more complex than previously thought. Article

> Ensur, Mystic Management's document control software, has been selected by Mersana Therapeutics for document and version control of key quality content, in conjunction with the introduction of a second lead product candidate. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.